Given the current underperformance of European banks and the downsizing of IBDs (e.g. DB, Barclays), how is advisory (M&A and equity/ debt underwriting) going to develop in the future?
Are independent advisors taking over?
(This applies in particular to European banks)
| +162 | Gifting Bonus to Parents? | 13 | 1d | |
| +129 | Dartmouth Partners Sucks. | 40 | 29m | |
| +103 | BofA Spiraling? | 46 | 4h | |
| +54 | Summer opportunities/suggestions for rising 12th grader | 23 | 10h | |
| +50 | Tips I Wish Someone Gave Me When I was Starting My Analyst Stint | 4 | 4d | |
| +46 | UBS 2024 Groups for Purely Exits | 29 | 11h | |
| +40 | Can anyone provide some insight into Canadian Target Schools | 29 | 14h | |
| +39 | Risks of lateral as a third year analyst | 8 | 1d | |
| +38 | Last minute college decisions (HC IB -> Life Sciences Buyside) | 9 | 1h | |
| +37 | COLLEGE PRESTIGE TIER LIST - 2024 | 27 | 8h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Personally I think industry wise I think definitely EBs (+ european boutiques like Robey Warshaw) + US BB will take over more market share that DB/UBS lose.
Not sure how specific firms will do but if I had to guess DB will always have a presence (german pride + solid historic performance) in EMEA especially with European lev fin although with the piss poor balance sheet I think it'll take at least 2-3 more years of restructuring before they think about any growth. CS is still a strong player in IB esp EMEA and the CEO just said they won't be downsizing anymore (albeit I believe he was referring to S&T more so). I think Barclays wants to continue its investment into IB and grow the group, have seen couple of hires within Chemicals/Industrials/HC in the US so I'd reckon they'd be continuing that for Europe (not sure which groups in particular though just making a guess). UBS I have no idea with all the focus on PWM/AM I'm surprised they're still decently strong with IB.
I think couple 3rd tier firms like BNP/Soc Gen/HSBC will be interesting. I think in the next couple of years some will completely be even more irrelevant (Soc Gen) whereas others (HSBC) have a chance maybe to gain a bit more market share.
Just my opinion based on what I'm hearing from buddies of mine in different firms and reading the news. Then again based in the US so I could be 100% wrong.
Est ex voluptatem omnis explicabo. Ut aperiam eum et ullam sed adipisci. Sit assumenda tempore quia aut. Minus voluptatum quaerat nihil eveniet est minima temporibus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...